You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Radium Ra 223 dichloride

Showing 51 - 75 of 1,687
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Patients Trial in Philadelphia (11C-Acetate)

Completed
  • Prostate Cancer Patients
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2022

PRORADIUM: Prospective Multi-centre Study of Prognostic Factors

Unknown status
  • Advanced Prostate Cancer
  • +2 more
  • Radium 223 55mBq/Kg every 4 weeks intravenously
  • Ferrol, A Coruña, Spain
  • +62 more
Jan 23, 2020

Radium-223 Dichloride Therapy on Radionuclide Bone Scan Lesions.

Completed
  • Bony Metastases From Castrate Refractory Prostate Cancer
  • Radium-223 dichloride
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 7, 2019

Prostate Cancer Trial in Boston (Radium-223, Pembrolizumab)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Aug 31, 2022

Evaluate Treatment Patterns of mCRPC Belgium Treated With

Completed
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223 (Xofigo, Bay88-8223)
  • Multiple Locations, Belgium
    Many Locations
May 19, 2020

Prostatic Tumors Trial in United States (Radium-223 dichloride (Xofigo, BAY88-8223), Abiraterone acetate, Prednisone)

Completed
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Scottsdale, Arizona
  • +18 more
Jul 4, 2019

Prostate Cancer Trial in Netherlands, United States (Docetaxel 75 mg/m2, Docetaxel 60 mg/m2, Radium-223)

Recruiting
  • Prostate Cancer
  • Docetaxel 75 mg/m2
  • +2 more
  • Gilbert, Arizona
  • +52 more
Feb 2, 2023

Prostate Cancer Metastatic, Bone Metastases Trial in Copenhagen (Injection of PET tracer 68Ga-NOTA-AE105, PET/CT)

Terminated
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Injection of PET tracer 68Ga-NOTA-AE105
  • PET/CT
  • Copenhagen, Denmark
    Rigshospitalet
Oct 11, 2019

Metastatic Castration-resistant Prostate Cancer, mCRPC, Prostate Cancer Trial in Melbourne (Lutetium-177 PSMA-I&T, Radium-223)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Sep 26, 2022

Prostate Cancer Trial in Baltimore (Radium-223, stereotactic ablative radiotherapy (SABR))

Recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins
May 25, 2022

Non-study Population of Symptomatic mCRPC Patients Treated With

Active, not recruiting
  • Prostate Cancer Metastatic
  • Bone Metastases
  • Blood tests
  • Amsterdam, Netherlands
  • +1 more
Apr 20, 2022

Biochemical Recurrent Prostate Cancer Trial run by the National Cancer Institute (NCI) (Radium-223, 18F Sodium Fluoride)

Recruiting
  • Biochemical Recurrent Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Non Small Cell Lung Cancer With Bone Metastatses Trial in Providence (Xofigo)

Completed
Has Results
  • Non Small Cell Lung Cancer With Bone Metastatses
  • Xofigo
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jan 29, 2021

Multi-academic Center Study of Xofigo Patients

Completed
  • Prostate Cancer, Castration Resistant
  • Whippany, New Jersey
    Bayer US
Oct 20, 2020

Prostate Cancer Trial in Toronto (Hyperpolarized Pyruvate (13C))

Recruiting
  • Prostate Cancer
  • Hyperpolarized Pyruvate (13C)
  • Toronto, Ontario, Canada
    Sunnybrook Health Sciences Centre
May 4, 2022

Prostate Cancer Trial in United States (Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone)

Completed
Has Results
  • Prostate Cancer
  • Concurrent use of Radium Ra 223 dichloride and Abiraterone Acetate plus Prednisone
  • Towson, Maryland
  • +4 more
Jan 22, 2018

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
Has Results
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Scottsdale, Arizona
  • +67 more
Jun 30, 2019

Assess Gamma H2AX Positivity in Circulating Prostate Cancer

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Blood Collection During Standard of Care Treatment
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 10, 2021

Hormone Refractory Prostate Cancer, Bone Metastases Trial (Radium-223 dichloride (BAY88-8223))

Completed
  • Hormone Refractory Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (BAY88-8223)
  • (no location specified)
Dec 17, 2018

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Prostatic Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223))

Completed
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Guangzhou, Guangdong, China
  • +26 more
Sep 18, 2018

Hypertension,Essential Trial in Seoul (AD-223A, AD-223B, AD-223C)

Not yet recruiting
  • Hypertension,Essential
  • Seoul, Korea, Republic of
    Hanyang University Hospital
Sep 19, 2023

TowardComprehensive Supportive Care Intervention for Older or

Completed
  • Metastatic Prostate Cancer
  • Daily and weekly triggered symptom monitoring
  • Toronto, Ontario, Canada
  • +1 more
May 17, 2022

GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers

Completed
  • Periodontitis, Adult
  • miRNA-223 & -214 detection
  • Fayoum, Egypt
    faculty of dentistry, Fayoum university
Sep 26, 2023

Radical Prostatectomy and External Beam Radiotherapy in mCRPC

Unknown status
  • Prostate Cancer
  • Radium223
  • Rome, Italy
    Policlinico Umberto I
Sep 30, 2019